Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation.
OBJECTIVE
Factors involved in hepatitis C virus (HCV) recurrence versus acute cellular rejection are not fully understood. The aim of the present study was to investigate whether patients with recurrence after liver transplantation (OLT) showed similar CD4(+)/CD25(+) cell frequency and function as those who became chronically infected.


METHODS
After written informed consent, we enrolled 20 patients (group A) who underwent OLT with HCV recurrence within 6 months. HCV-RNA and hypertransaminasemia were used to assess the reactivation of viral hepatitis. CD4(+)/CD25(+) T cells were enumerated using a flow cytometry assay, gated on CD3 cells, stained for FoxP3. After immunomagnetic sorting (Dynal, Oslo, NW), Treg suppressor activity was measured, as the ability to inhibit proliferation of autologous CD4(+)/CD25(-) T cells (anti-CD3/CD28 stimulation-1:2, 1:20 ratio). Eight patients with acute hepatitis C who evolved to a chronic infection after 6 months (group B) were used as positive controls, while 10 healthy individuals were negative controls (group C).


RESULTS
We did not observe any difference in CD4(+)/CD25(+) frequency or function among group A compared with group B (CD4(+)/CD25(+) = 14% +/- 2% versus CD4(+)/CD25(+) = 16% +/- 3%), although both groups were significantly increased with respect to group A (CD4(+)/CD25(+) = 6% +/- 3%; Mann-Whitney U test, P < .01).


CONCLUSIONS
Patients developing HCV recurrence after OLT have the same immunoregulatory network as patients with acute hepatitis C evolving to persistent infection, likely suggesting that CD4(+)/CD25(+) numbers may be a marker to predict recurrence of HCV after OLT.
Perrella
A
A
Liver Transplant Unit Hospital A. Cardarelli, Naples, Italy.
Arenga
G
G
Pisaniello
D
D
Rampone
B
B
Di Costanzo
G G
GG
Atripaldi
L
L
Esposito
C
C
Di Florio
E
E
Perrella
O
O
Cuomo
O
O
D000328:Adult; D015703:Antigens, CD / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry; D006509:Hepatitis B / Q000097:blood / Q000453:epidemiology / Q000276:immunology / Q000601:surgery; D006526:Hepatitis C / Q000097:blood / Q000453:epidemiology* / Q000276:immunology* / Q000601:surgery; D006801:Humans; D053645:Interleukin-2 Receptor alpha Subunit / Q000097:blood*; D016031:Liver Transplantation / Q000009:adverse effects*; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D012008:Recurrence; D012189:Retrospective Studies; D013601:T-Lymphocytes / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D000637:Transaminases / Q000097:blood
D015703:Antigens, CD; D015415:Biomarkers; D053645:Interleukin-2 Receptor alpha Subunit; D012367:RNA, Viral; D000637:Transaminases